This study investigates how different doses of an investigational medication, referred to as DFMO, affect the stress levels of beta cells in the body. Beta cells are responsible for producing insulin, and the study aims to see if the medication can help preserve something called c-peptide, which is a part of insulin production.
Participants in this study will undergo various procedures to monitor the effects of the investigational medication. These procedures may include blood tests and other assessments to measure the stress on beta cells and the levels of c-peptide.
- Who can participate: Individuals diagnosed with type 1 diabetes within the past 2 to 8 months and who have normal hearing are eligible to participate. Participants should not have any severe active diseases affecting diet or requiring chronic medication, except for well-controlled hypothyroidism and mild asthma.
- Study details: Participants will be required to take the investigational medication in pill form, and their health will be monitored through various tests. The study may include a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand
